WallStreetZenWallStreetZen

NYSE: CL
Colgate Palmolive Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CL past earnings growth

How has CL's earnings growth performed historically?
Company
-26.75%
Industry
-8.97%
Market
36.76%
CL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CL's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CL's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CL past revenue growth

How has CL's revenue growth performed historically?
Company
2.3%
Industry
0.04%
Market
163.96%
CL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CL earnings and revenue history

Current Revenue
$17.7B
Current Earnings
$1.9B
Current Profit Margin
10.9%
CL's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CL Return on Equity

Current Company
448.4%
Current Industry
98.2%
Current Market
-8.3%
CL's Return on Equity (448.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CL announces earnings.

CL Return on Assets

Current Company
12.3%
Current Industry
11%
CL is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CL Return on Capital Employed

Current Company
23.64%
Current Industry
21.1%
CL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CL vs Household & Personal Product Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CL$17.74B$3.34B$1.93B+3.03%-2.50%
HLN$11.50B$1.91B$1.67BN/AN/A
KMB$20.18B$3.27B$1.78B+1.89%-2.84%
EL$16.36B$2.80B$1.49B+5.08%+7.44%
CHD$5.31B$1.20B$736.70M+7.84%+11.35%
View Top Household & Personal Product Stocks

Colgate Palmolive Co Earnings & Revenue FAQ

What were CL's earnings last quarter?

On Invalid Date, Colgate Palmolive Co (NYSE: CL) reported Q3 2022 earnings per share (EPS) of $0.74, up 1.33% year over year. Total Colgate Palmolive Co earnings for the quarter were $618.00 million. In the same quarter last year, Colgate Palmolive Co's earnings per share (EPS) was $0.75.

If you're new to stock investing, here's how to buy Colgate Palmolive Co stock.

What was CL's earnings growth in the past year?

As of Q1 2023, Colgate Palmolive Co's earnings has grown -26.75% year over year. This is 17.79 percentage points lower than the US Household & Personal Products industry earnings growth rate of -8.97%. Colgate Palmolive Co's earnings in the past year totalled $1.93 billion.

What was CL's revenue last quarter?

On Invalid Date, Colgate Palmolive Co (NYSE: CL) reported Q3 2022 revenue of $4.46 billion up 0.93% year over year. In the same quarter last year, Colgate Palmolive Co's revenue was $4.41 billion.

What was CL's revenue growth in the past year?

As of Q1 2023, Colgate Palmolive Co's revenue has grown 2.3% year over year. This is 2.26 percentage points higher than the US Household & Personal Products industry revenue growth rate of 0.04%. Colgate Palmolive Co's revenue in the past year totalled $17.74 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.